A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
We compare and contrast the expected duration and number of infections and deaths averted among several designs for clinical trials of COVID-19 vaccine candidates, including traditional and adaptive randomized clinical trials and human challenge trials. Using epidemiological models calibrated to the...
Main Authors: | Donald A Berry, Scott Berry, Peter Hale, Leah Isakov, Andrew W Lo, Kien Wei Siah, Chi Heem Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0244418 |
Similar Items
-
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
by: Berry, Donald A., et al.
Published: (2021) -
Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs
by: Lo, Andrew W, et al.
Published: (2021) -
Estimation of clinical trial success rates and related parameters
by: Wong, Chi Heem, et al.
Published: (2020) -
Issue 1 (Machine Learning with Statistical Imputation for Predicting Drug Approval)
by: Lo, Andrew W, et al.
Published: (2021) -
Multimorbidity and mortality: A data science perspective
by: Siah, Kien Wei, et al.
Published: (2022)